Skip to content
10-Q

Quarterly Report

BIOMARIN PHARMACEUTICAL INC BMRN

0001048477-25-000090

← back to feed
Filed
Aug 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 28, 2025 192.01M sh
Shares Diluted Q2 2025 · Jun 30, 2025 197.09M sh
Shares Diluted Q2 2025 · Jun 30, 2025 196.64M sh
Shares Diluted Q2 2025 · Jun 30, 2024 200.51M sh
Shares Diluted Q2 2025 · Jun 30, 2024 200.14M sh
Capex Q2 2025 · Jun 30, 2025 $33.87M
Capex Q2 2025 · Jun 30, 2024 $47.43M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $359.67M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $165.73M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $1.21B
Cash And Equivalents Q2 2025 · Dec 31, 2024 $942.84M
Stockholders Equity Q2 2025 · Jun 30, 2025 $6.03B
Stockholders Equity Q2 2025 · Mar 31, 2025 $5.79B
Stockholders Equity Q2 2025 · Dec 31, 2024 $5.66B
Stockholders Equity Q2 2025 · Jun 30, 2024 $5.29B
Stockholders Equity Q2 2025 · Mar 31, 2024 $5.07B
Stockholders Equity Q2 2025 · Dec 31, 2023 $4.95B
Current Liabilities Q2 2025 · Jun 30, 2025 $684.25M
Current Liabilities Q2 2025 · Dec 31, 2024 $606.99M
Total Liabilities Q2 2025 · Jun 30, 2025 $1.43B
Total Liabilities Q2 2025 · Dec 31, 2024 $1.33B
Current Assets Q2 2025 · Jun 30, 2025 $3.81B
Current Assets Q2 2025 · Dec 31, 2024 $3.23B
Total Assets Q2 2025 · Jun 30, 2025 $7.46B
Total Assets Q2 2025 · Dec 31, 2024 $6.99B
Eps Diluted Q2 2025 · Jun 30, 2025 $1.23
Eps Diluted Q2 2025 · Jun 30, 2025 $2.19
Eps Diluted Q2 2025 · Jun 30, 2024 $0.55
Eps Diluted Q2 2025 · Jun 30, 2024 $1.01
Eps Basic Q2 2025 · Jun 30, 2025 $1.25
Eps Basic Q2 2025 · Jun 30, 2025 $2.23
Eps Basic Q2 2025 · Jun 30, 2024 $0.56
Eps Basic Q2 2025 · Jun 30, 2024 $1.03
Sga Expense Q2 2025 · Jun 30, 2025 $232.28M
Sga Expense Q2 2025 · Jun 30, 2025 $438.4M
Sga Expense Q2 2025 · Jun 30, 2024 $263.03M
Sga Expense Q2 2025 · Jun 30, 2024 $488.94M
Rd Expense Q2 2025 · Jun 30, 2025 $161.31M
Rd Expense Q2 2025 · Jun 30, 2025 $320.04M
Rd Expense Q2 2025 · Jun 30, 2024 $183.79M
Rd Expense Q2 2025 · Jun 30, 2024 $388.77M
Net Income Q2 2025 · Jun 30, 2025 $240.53M
Net Income Q2 2025 · Jun 30, 2025 $426.22M
Net Income Q2 2025 · Jun 30, 2024 $107.17M
Net Income Q2 2025 · Jun 30, 2024 $195.84M
Operating Income Q2 2025 · Jun 30, 2025 $276.89M
Operating Income Q2 2025 · Jun 30, 2025 $500.78M
Operating Income Q2 2025 · Jun 30, 2024 $120.45M
Operating Income Q2 2025 · Jun 30, 2024 $208.91M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $150.09M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $301.65M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $130.46M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $255.64M
Revenue Q2 2025 · Jun 30, 2025 $825.41M
Revenue Q2 2025 · Jun 30, 2025 $1.57B
Revenue Q2 2025 · Jun 30, 2024 $712.03M
Revenue Q2 2025 · Jun 30, 2024 $1.36B